Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Elaine Tat Lam

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Lam, Elaine

One or more keywords matched the following properties of Lam, Elaine

Property	Value
full name	Elaine Tat Lam
label	Lam, Elaine
last name	Lam

One or more keywords matched the following items that are connected to Lam, Elaine

Item Type	Name
Academic Article	A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors.
Academic Article	Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.
Academic Article	Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Academic Article	Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors.
Academic Article	A rare case of metastatic renal epithelioid angiomyolipoma.
Academic Article	Prostate cancer: celecoxib trampled in the STAMPEDE trial.
Academic Article	Axitinib, a new therapeutic option in renal cell carcinoma.
Academic Article	Tivozanib: practical implications for renal cell carcinoma and other solid tumors.
Academic Article	Nonseminomatous germ cell tumor of testis and interrupted treatment.
Academic Article	Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancer.
Academic Article	Collision renal cell papillary and medullary carcinoma in a 66-year-old man.
Academic Article	Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies.
Academic Article	Kidney cancer, version 2.2014.
Academic Article	A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma.
Academic Article	Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
Academic Article	Kidney cancer, version 3.2015.
Academic Article	SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.
Academic Article	Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors.
Academic Article	Testicular Cancer, Version 2.2015.
Academic Article	Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).
Academic Article	Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Academic Article	A Patient With Newly Diagnosed Metastatic Type 2 Papillary Renal Cell Carcinoma.
Academic Article	Upfront Chemotherapy for Metastatic Prostate Cancer.
Academic Article	Does the Renal Parenchyma Adjacent to the Tumor Contribute to Kidney Function? A Critical Analysis of Glomerular Viability in Partial Nephrectomy Specimens.
Academic Article	Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors.
Academic Article	Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.
Academic Article	Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.
Academic Article	Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Academic Article	Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.
Academic Article	Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Academic Article	Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.
Academic Article	Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2a Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.
Academic Article	Renal cell carcinoma: a review of biology and pathophysiology.
Academic Article	Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer.
Academic Article	Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Academic Article	The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer.
Academic Article	Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Academic Article	NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.
Academic Article	Evaluation of fosaprepitant-associated hypersensitivity reactions at a National Cancer Center.
Academic Article	Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Na?ve Metastatic Renal Cell Carcinoma.
Academic Article	Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline Review.
Academic Article	Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study.
Academic Article	Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
Academic Article	Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors.
Academic Article	Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
Academic Article	Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Academic Article	NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Academic Article	Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.
Academic Article	Patient satisfaction with ExtaviPro? 30G, a new auto-injector for administering interferon ?-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.
Academic Article	A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers.
Academic Article	A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma.
Academic Article	Tumor flare of brain metastases upon dose interruption of sunitinib in a patient with metastatic renal cell carcinoma.
Academic Article	Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal cell carcinoma.
Academic Article	Spontaneous regression of an extragonadal seminomatous germ cell tumor.
Academic Article	Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors.
Academic Article	Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma.
Academic Article	Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.
Academic Article	Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Academic Article	Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma.
Academic Article	Metastatic Renal Cell Carcinoma With Sarcomatoid Features.
Academic Article	ADXS31142 Immunotherapy ? Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.
Academic Article	A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
Academic Article	Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations.
Academic Article	Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.
Academic Article	Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors.
Academic Article	Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
Academic Article	Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
Academic Article	A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
Academic Article	Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer.
Academic Article	Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.
Academic Article	Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Academic Article	Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis.
Academic Article	Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.
Academic Article	Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.
Academic Article	Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.

Search Criteria

L Selectin